EGLN2
EGLN2 (egl-9 family hypoxia inducible factor 2, also known as PHD1 or HIFPH1) is a nuclear prolyl hydroxylase that acts as a cellular oxygen sensor. Under normal oxygen levels it hydroxylates HIF alpha proteins and marks them for degradation. Browse Assay Genie's current range of EGLN2 research reagents below, or read on for the biology behind the target.
EGLN2 is a prolyl hydroxylase that mediates hydroxylation of proline residues in target proteins, including ATF4, IKBKB, CEP192 and HIF1A. Substrates are preferentially recognised through a LXXLAP motif. As a cellular oxygen sensor, EGLN2 catalyses, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. It hydroxylates a specific proline in each of the oxygen-dependent degradation domains of HIF1A (NODD and CODD) and also hydroxylates HIF2A, with a preference for the CODD site in both. Hydroxylated HIFs are targeted for proteasomal degradation through the von Hippel-Lindau ubiquitination complex.
When oxygen is limiting, the hydroxylation reaction is attenuated. HIFs then escape degradation, translocate to the nucleus, heterodimerise with HIF1B and drive increased expression of hypoxia-inducible genes. Beyond HIF, EGLN2 links oxygen sensing to the cell cycle and primary cilia formation by hydroxylating the centrosome component CEP192, which promotes its ubiquitination and degradation. It also hydroxylates IKBKB, mediating NF-kappa-B activation in hypoxic conditions, and hydroxylates ATF4, reducing ATF4 protein stability. EGLN2 is involved in regulating hypoxia tolerance and apoptosis in cardiac and skeletal muscle, and in susceptibility to normoxic oxidative neuronal death.
The EGLN2 gene belongs to the Egl-9 family of hypoxia inducible factors and was previously named egl nine homolog 2 (C. elegans). According to NCBI Gene, alternative splicing produces multiple transcript variants, and read-through transcription occurs between this gene and the upstream RAB4B gene. Mouse and rat both carry an Egln2 ortholog.
EGLN2 hydroxylates HIF alpha subunits under normoxia, making it a core component for studying how cells respond to changing oxygen levels.
Hydroxylated HIF1A and HIF2A are recognised by the von Hippel-Lindau complex and degraded by the proteasome, a route in which EGLN2 acts as the modifying enzyme.
By hydroxylating CEP192, EGLN2 connects oxygen sensing to centrosome regulation and primary cilia formation.
EGLN2 is involved in hypoxia tolerance and apoptosis in cardiac and skeletal muscle, and in susceptibility to normoxic oxidative neuronal death.
EGLN2 is a prolyl hydroxylase and oxygen sensor. In normoxia it forms 4-hydroxyproline in HIF1A and HIF2A, which sends them for proteasomal degradation via the von Hippel-Lindau complex. In hypoxia this activity falls, so HIFs accumulate and activate hypoxia-inducible genes.
EGLN2 is also known as PHD1 and HIFPH1, and its UniProt name is prolyl hydroxylase EGLN2. The HGNC name is egl-9 family hypoxia inducible factor 2, and an earlier name was egl nine homolog 2 (C. elegans). NCBI Gene notes multiple transcript variants arising from alternative splicing.
Yes. EGLN2 also hydroxylates CEP192, linking oxygen sensing to cell cycle and primary cilia formation. It hydroxylates IKBKB, supporting NF-kappa-B activation in hypoxia, and ATF4, lowering its stability. Mouse and rat Egln2 orthologs exist; check the datasheet of any product for its validated reactivity.
Other members of the Egl-9 family of hypoxia inducible factor prolyl hydroxylases with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96KS0; product specifications from Assay Genie datasheets.